A randomised study comparing the safety and immunogenicity of a conjugate vaccine combination containing meningococcal group C and pneumococcal capsular polysaccharide - CRM197 with a meningococcal group C conjugate vaccine in healthy infants: challenge phase

A randomised study comparing the safety and immunogenicity of a conjugate vaccine combination containing meningococcal group C and pneumococcal capsular polysaccharide - CRM197 with a meningococcal group C conjugate vaccine in healthy infants: challenge phase

Background: A combination nonavalent pneumococcal-group C meningococcal conjugate vaccine (Pnc9-MenC) was previously found to be safe and immunogenic when administered to infants at 2, 3 and 4 monts. This study describes the persistence of immunity at 12 months of age and the immunologic response to...

Full description

Bibliographic Details
Main Authors:	Riddell, A, Buttery, J, McVernon, J, Chantler, T, Lane, L, Bowen-Morris, J, Diggle, L, Morris, R, Lockhart, S, Pollard, A, Cartwright, K, Moxon, E
Other Authors:	International Society for Vaccines
Format:	Journal article
Language:	English
Published:	Elsevier 2007
Subjects:	Vaccinology Paediatrics

Similar Items

A randomized study comparing the safety and immunogenicity of a conjugate vaccine combination containing meningococcal group C and pneumococcal capsular polysaccharide--CRM197 with a meningococcal group C conjugate vaccine in healthy infants: challenge phase.
by: Riddell, A, et al.
Published: (2007)

Quadrivalent meningococcal conjugate vaccines
by: Pace, D, et al.
Published: (2009)

B cell responses to conjugate and polysaccharide meningococcal vaccines
by: Ramasamy, M
Published: (2012)

Immunogenicity and immunologic memory of meningococcal C conjugate vaccine in premature infants.
by: Collins, C, et al.
Published: (2005)

The kinetics and phenotype of the human B-cell response following immunization with a heptavalent pneumococcal-CRM197 conjugate vaccine
by: Clutterbuck, E, et al.
Published: (2006)

Impact of serogroup A meningococcal conjugate vaccine for Africa
by: James M. Stuart
Published: (2018-05-01)

Immunogenicity and safety of a combination pneumococcal-meningococcal vaccine in infants: a randomized controlled trial.
by: Buttery, J, et al.
Published: (2005)

Global epidemiology of meningococcal disease and vaccine efficacy
by: Pollard, A
Published: (2004)

A randomised, double-blind, controlled trial of the immunogenicity and tolerability of a meningococcal group C conjugate vaccine in young British infants.
by: English, M, et al.
Published: (2000)

Vaccine prevention of meningococcal disease, coming soon?
by: Morley, S, et al.
Published: (2001)

Public policy for meningococcal vaccination
by: J. Claire Cameron
Published: (2018-05-01)

CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells.
by: Kelly, D, et al.
Published: (2006)

Effectiveness analyses may underestimate protection of infants after group C meningococcal immunization
by: Vu, D, et al.
Published: (2006)

Serogroup c meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization
by: Snape, M, et al.
Published: (2006)

Immunogenicity and safety of a low-dose diphtheria, tetanus and acelular pertussis combination vaccine with either inactivated or oral polio vaccine as a pre-school booster in UK children
by: Collins, C, et al.
Published: (2004)

Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999-2000 and response to a booster: a phase 4 clinical trial
by: Perrett, K, et al.
Published: (2010)

An update of clinical experience with the quadrivalent meningococcal ACWY-CRM conjugate vaccine
by: Pavitra Keshavan, et al.
Published: (2018-10-01)

Plasma and memory B-cell kinetics in infants following a primary schedule of CRM 197-conjugated serogroup C meningococcal polysaccharide vaccine.
by: Kelly, D, et al.
Published: (2009)

Correlation of group C meningococcal conjugate vaccine response with B- and T-lymphocyte activity.
by: James B Wing, et al.
Published: (2012-01-01)

Meningococcal vaccines: past, present, and future perspectives
by: Seyed Davar Siadat and Dariush Norouzian
Published: (2007-10-01)

Of mice and MenB: assessing the immune mechanisms underlying meningococcal capsular group B vaccines in mice
by: Sheerin, D
Published: (2019)

Quadrivalent meningococcal conjugate vaccines.
by: Pace, D, et al.
Published: (2009)

Correction: Correlation of Group C Meningococcal Conjugate Vaccine Response with B- and T-Lymphocyte Activity
Published: (2012-01-01)

Correction: Correlation of Group C Meningococcal Conjugate Vaccine Response with B- and T-Lymphocyte Activity.
by: James B. Wing, et al.
Published: (2012-01-01)

Vaccines against Meningococcal Diseases
by: Mariagrazia Pizza, et al.
Published: (2020-10-01)

Meningococcal polysaccharide-protein conjugate vaccines.
by: Snape, MD, et al.
Published: (2005)

Immunogenicity and safety of a quadrivalent meningococcal polysaccharide CRM conjugate vaccine in infants and toddlers
by: Miguel Tregnaghi, et al.
Published: (2014-09-01)

Immunologic memory with no detectable bactericidal antibody response to a first dose of meningococcal serogroup C conjugate vaccine at four years.
by: McVernon, J, et al.
Published: (2003)

Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity.
by: Maiden, M, et al.
Published: (2008)

Meningococcal disease. Meningococcal conjugate polysaccharide vaccines and new generation vaccines. Report 3
by: M. V. Abramtseva, et al.
Published: (2018-02-01)

Meningococcal Carriage among Adolescents after Mass Meningococcal C Conjugate Vaccination Campaigns in Salvador, Brazil.
by: Amélia Maria Pithon Borges Nunes, et al.
Published: (2016-01-01)

Meningococcal disease before and after the introduction of meningococcal serogroup C conjugate vaccine. Federal District, Brazil
by: Márcia de Cantuária Tauil, et al.
Published: (2014-07-01)

Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease
by: Hedari CP, et al.
Published: (2014-04-01)

Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants
by: Ruggeberg, J, et al.
Published: (2007)

Progress in meningococcal conjugate vaccine development and use
Published: (2020-06-01)

Meningococcal conjugate vaccines: optimizing global impact
by: Terranella A, et al.
Published: (2011-09-01)

The impact of the meningococcal serogroup C conjugate vaccine in Canada between 2002 and 2012.
by: Sadarangani, M, et al.
Published: (2014)

Vi polysaccharide-protein conjugate vaccine for the prevention of typhoid fever in children: hope or hype?
by: Pulickal, A, et al.
Published: (2007)

Maintaining protection against invasive bacteria with protein - polysaccharide conjugate vaccines
by: Pollard, A, et al.
Published: (2009)

Plasma and memory B-cell kinetics in infants following a primary schedule of CRM197-conjugated serogroup C meningococcal polysaccharide vaccine (vol 127, pg 134, 2009)
by: Kelly, D, et al.
Published: (2011)